FDA approves KERYDIN™ (tavaborole) for toenail onychomycosis

Posted on July 8, 2014 by admin

Press Release: FDA Approves Anacor Pharmaceuticals’ KERYDIN™ (Tavaborole) Topical Solution, 5% for the Treatment of Onychomycosis of the Toenails July 08, 2014 Quote: Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) today announced that the U.S.

Originally posted here:
FDA approves KERYDIN™ (tavaborole) for toenail onychomycosis

Related posts:

  1. Efinaconazole 10% solution in the treatment of toenail onychomycosis
  2. Efinaconazole 10% solution in the treatment of toenail onychomycosis
  3. FDA approves Victoza (liraglutide) for type 2 diabetes treatment
  4. Lasers for toenail onychomycosis
  5. Posaconazole for Toenail Onychomycosis.
  6. Posaconazole for Toenail Onychomycosis.
  7. Clinical diagnosis of toenail onychomycosis – diagnostic rules
  8. Excilor Treatment for Onychomycosis
  9. Laser Treatment for Toenail Fungus
  10. Laser treatment for toenail fungus
  11. Laser Treatment for Onychomycosis
  12. Excilor Treatment for Onychomycosis
  13. Laser Comparison in treatment of Onychomycosis – Fungal nails
  14. advice – nail surgery – onychomycosis
  15. Laser Comparison in treatment of Onychomycosis – Fungal nails
This entry was posted in Podiatry, Podiatry Arena and tagged . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *